In an effort to uphold standards of clinical excellence and elevate standards of care f or those with cardiological conditions,

Apollo Hospitals Uses Synergistic Device Strategy for Complex Heart Block Treatment

*Synergy offers more thorough clearance of heart blocks with less complications 

*Team aces live demo of procedures on global platforms, wins acclaim

*India has one of the highest burdens of cardiovascular diseases in the world

Chennai, 25 October 2023: In an effort to uphold standards of clinical excellence and elevate standards of care f or those with cardiological conditions, a team of doctors from Apollo Hospital have implemented a pioneering s et of techniques to treat complex heart blocks.  The team, led by interventional cardiologist Dr Sengottuvelu G, recently demonstrated the specialized techniques at prestigious international forums in association with Asian Pacific Society of Interventional Cardiology and European Bifurcation Club and received peer acclaim.

Complex Percutaneous Coronary Intervention (Complex PCI) are stent procedures done in advanced coronary artery disease. The success of these procedures can be challenging as the burden of cardiovascular diseases in India is high and patients seek medical attention late only when their heart condition has reached an advanced and often critical stage. Late presentation can complicate the treatment process and increase the complexity of interventions.

Recognising these unique challenges, Apollo Hospitals has established an evolving approach that combines a su ite of advanced techniques such as Laser, Rotablation, Shock Wave Lithotripsy, Orbital Atherectomy and Cuttin g Balloon. These techniques are customised and combined to meet the patients need to reduce complications an d increase success rates.

Complex PCI in India involves addressing intricate coronary lesions, often characterized by heavy calcification or total occlusions (blocks). These lesions can significantly impede blood flow to the heart, leading to symptoms like chest pain and increased risk of heart attacks.

Notable cases include the successful treatment of a 75-year-old lady with a densely calcified lesion, the recovery of a 54-year-old doctor with left main disease and the recovery of a 77-year-old patient  with previous bypass su rgery who had  a cardiac arrest at his house.

The application of these ground-breaking procedures such as TRILASER TRIPSY, ROTASHOCK and ORBICUT by the Apollo Hospitals team have not only improved their survival and quality of their life but have also raised the bar for the treatment of complex heart blocks.

Ms Suneeta Reddy, Managing Director, Apollo Hospitals Group, said, “Hearty congratulations to Dr Sengottuve lu and his team on the breakthrough procedures! This feat is testimony to the fact that our healthcare model ma tches global standards, is in sync with the latest in medicine and is powered by top minds. Our surgeons bring ski ll, experience and insight to their practice and we are delighted that they have earned acclaim on the global stag e. We at Apollo Hospitals recognize that cardiology is a key specialty and will thus continue to invest in cutting-e dge equipment in this space to ensure our doctors are able to deliver exemplary care and achieve optimal outco mes.”

Dr Sengottuvelu, Interventional Cardiologist and Clinical Lead, Structural Heart Disease Programme, Apollo Ho spitals Group, said, “The cardiovascular disease burden in our country is high, due to a range of factors such as lif estyle, stress and genetics. As a result, we are faced with a vast and diverse case pattern. However, we as medica l professionals are required to customize solutions in line with the needs of our patients. By combining various te chniques, we have created comprehensive solutions to deal with the specific issue of blockages and enhance life expectancy. We have observed that this synergy-based approach has significantly improved the success and ens ured the best long term outcomes for our patients.”

About Apollo Hospitals:

It was in 1983, that Dr Prathap C Reddy made a pioneering endeavor by launching India’s first corporate hospital – Apollo Hospitals in Chennai. Now, as Asia’s foremost trusted integrated healthcare group, its presence includes over 12,000 beds across 72 Hospitals and 5000 pharmacies, over 400 Primary Care clinics and 1228 Diagnostic c entres, 700 plus Teleclinics, over 15 medical education centres and a Research Foundation with a focus on glob a l Clinical Trials. The most recent investment was the commissioning of South East Asia’s very first Proton The ra py Centre in Chennai.

Every four days, the Apollo Hospitals Group touches a million lives, in its mission to bring healthcare of interna ti onal standards within the reach of every individual. In a rare honour, the Government of India had issued a com memorative stamp in recognition of Apollo’s contribution, the first for a healthcare organization. Apollo Hospit als Chairman, Dr Prathap C Reddy, was conferred with the prestigious Padma Vibhushan in 2010.

For 40 years, the Apollo Hospitals Group has continuously excelled and maintained leadership in medical innov ation, world-class clinical services and cutting-edge technology. Its hospitals are consistently ranked amongst t he best hospitals in the country for advanced medical services.